Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study

Conclusion: In usual clinical care, pediatric patients with bipolar disorder treated with lurasidone had a significantly lower risk of all-cause and psychiatric hospitalizations when compared to aripiprazole and olanzapine, but not quetiapine or risperidone.PMID:34647502 | DOI:10.1080/13696998.2021.1993862
Source: Journal of Medical Economics - Category: Health Management Authors: Source Type: research